EUR 13,69
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Very Good. Clinical Trials in Osteoporosis This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. .
EUR 13,69
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Very Good. Shipped within 24 hours from our UK warehouse. Clean, undamaged book with no damage to pages and minimal wear to the cover. Spine still tight, in very good condition. Remember if you are not happy, you are covered by our 100% money back guarantee.
Lingua: Inglese
Editore: London, Springer, 2006
Da: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Germania
Membro dell'associazione: GIAQ
EUR 7,80
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Wie neu. 2nd ed. 274 S.; Ill. Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 630.
EUR 30,51
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. 308 Illus.
Condizione: New. pp. 308 2nd Edition.
EUR 31,03
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. 308.
EUR 39,66
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Good. 2nd ed. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Lingua: Inglese
Editore: London, Springer London/Imprint: Springer., 2002
ISBN 10: 1852332298 ISBN 13: 9781852332297
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
Prima edizione
EUR 18,00
Quantità: 1 disponibili
Aggiungi al carrello1st ed. 2002. Softcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Da: UK BOOKS STORE, London, LONDO, Regno Unito
EUR 64,16
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Brand New! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
EUR 64,45
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Sehr gut. 256 Seiten ex Library Book aus einer wissenschafltichen Bibliothek Sprache: Englisch Gewicht in Gramm: 523.
EUR 8,42
Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: Wie neu. Gebraucht - Wie neu Mängelex.: Lagerspuren, Zustand: Gut, XIII, 258 pp. 48 figs. About this book: Clinical Trials in Osteoporosis is a practical handbook on clinical trials in the growing field of osteoporosis. Topics covered include study design, technical issues, data collection, quality assurance, data analysis and presentation. It aims to take the user through the process step-by-step from start to finish, also providing a background on regulatory guidelines, ethical implications, endpoints, current therapies and the ideal drug to use. There are no other books at present that specifically address the issue of clinical trials in osteoporosis. A number of issues dealt with in this book have been brought together in one publication for the first time. Clinical Trials in Osteoporosis is intended to serve as a practical manual for clinicians and scientists coming to the subject new and to provide a standard for existing centers to measure themselves against. Written for rheumatologists, endocrinologists, obstetrics & gynecology specialists.
Condizione: New. pp. xiii + 258 Index.
EUR 112,19
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. xiii + 258 Illus.
EUR 112,12
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 113,61
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. xiii + 258.
EUR 127,46
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 112,11
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 131,59
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 33,72
Quantità: 1 disponibili
Aggiungi al carrellosoft cover. Condizione: Wie neu. Gebraucht - Wie neu -COLING. MILLER ANDDEREKPEARSON 1. 1. Why a Book about Clinical Trials in Osteoporosis There have been many books published about the design, conduct, and analysis of clinicaltrials. Whyareosteoporosistrialsaspecialcasethatdeserveabookoftheir own There are three main reasons. First, most diseases have a well-understood definitionandaetiology. Osteoporosisisadiseasethatisunderstoodbythosewo- ing within the subspecialty, but currently there is no definition that is agreeable to both medical and scientific communities and its aetiology is poorly understood. It is within this framework that the pharmaceutical industry is trying to develop new treatmentsfortheso-called'silentepidemic'. In layman's terms, the disease of osteoporosis is defined as 'brittle bones occurring in the elderly that could lead to fractures. 'The classical definition was 'a bony fracture caused by minimal trauma owing to a loss in bone mineral. ' A published consensus definition states that osteoporosis is 'a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to 1 fractures. ' The National Institutes of Health (NIH) Consensus Conference Statement on Osteoporosis Prevention, Diagnosis, and Therapy states that 'osteoporosis is a skeletal disorder characterized by compromised bone strength 2 predisposing to an increased risk of fracture. ' The World Health Organization (WHO) operationally defines osteoporosis as 'bone density 2. 5 standard dev- tions (SDs) below the mean for young white adult women at lumbar spine, 3 femoralneck,orforearm'. Itisnowrecommendedthatthediagnosticuseofthis 4 definition is restricted to bone density of the femur.
EUR 118,24
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 124,02
Quantità: Più di 20 disponibili
Aggiungi al carrelloKartoniert / Broschiert. Condizione: New. A practical manual for clinicians/scientists coming to the subject new - provides a standard for existing centers to measure themselves againstSpecifically addresses clinical trials in osteoporosis (no such other book is in the Library of Congress.
EUR 152,89
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
EUR 153,14
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware - COLING. MILLER ANDDEREKPEARSON 1. 1. Why a Book about Clinical Trials in Osteoporosis There have been many books published about the design, conduct, and analysis of clinicaltrials. Whyareosteoporosistrialsaspecialcasethatdeserveabookoftheir own There are three main reasons. First, most diseases have a well-understood definitionandaetiology. Osteoporosisisadiseasethatisunderstoodbythosewo- ing within the subspecialty, but currently there is no definition that is agreeable to both medical and scientific communities and its aetiology is poorly understood. It is within this framework that the pharmaceutical industry is trying to develop new treatmentsfortheso-called'silentepidemic'. In layman's terms, the disease of osteoporosis is defined as 'brittle bones occurring in the elderly that could lead to fractures. 'The classical definition was 'a bony fracture caused by minimal trauma owing to a loss in bone mineral. ' A published consensus definition states that osteoporosis is 'a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to 1 fractures. ' The National Institutes of Health (NIH) Consensus Conference Statement on Osteoporosis Prevention, Diagnosis, and Therapy states that 'osteoporosis is a skeletal disorder characterized by compromised bone strength 2 predisposing to an increased risk of fracture. ' The World Health Organization (WHO) operationally defines osteoporosis as 'bone density 2. 5 standard dev- tions (SDs) below the mean for young white adult women at lumbar spine, 3 femoralneck,orforearm'. Itisnowrecommendedthatthediagnosticuseofthis 4 definition is restricted to bone density of the femur.